Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of ledipasvir/sofosbuvir in adults with chronic hepatitis C virus infection has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 3 | Status: COMPLETED | Results posted: 2017-05-10